Climb Biotherapeutics, Inc. (CLYM)
Market Open
15 Jun, 14:50
NASDAQ (NMS) NASDAQ (NMS) Primary $
11. 50
+0.06
+0.5245%
$
780.03M Market Cap
- P/E Ratio
- Div Yield
136,066 Volume
0 Eps
$ 11.44
Previous Close Want to track CLYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Climb Biotherapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| GS George Song Superstring Capital Management LP | 199,209 | $1.36M | $2.29M | $922,337.31 | 67.59% |
 Zachary Canonico DIADEMA PARTNERS LP | 286,126 | $1.96M | $3.24M | $1.28M | 65.11% |
